Fig. 3From: Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma(A) ROC analysis of serum LRG1 to distinguish patients with ccRCC from those without cancer. (B) ROC analysis of serum LRG1 to distinguish patients with ccRCC from those with non-ccRCCBack to article page